PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter

This publication has 66 references indexed in Scilit:

• Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [11C]PE2I in healthy volunteers
  Nuclear Medicine and Biology, 2007
• Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
  American Journal of Psychiatry, 2002
• Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells
  Neurochemistry International, 2001
• Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease
  Synapse, 1999
• Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)
  Nuclear Medicine and Biology, 1998
• [18F]β-CIT-FP is superior to [11C]β-CIT-FP for quantitation of the dopamine transporter
  Nuclear Medicine and Biology, 1997
• IPT: A novel iodinated ligand for the CNS dopamine transporter
  Synapse, 1995
• Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons
  Annals of Neurology, 1994
• SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain
  Journal of Neural Transmission, 1993
• A simple synthesis of [11C]methyl triflate
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992